Related Experiment Video
Updated: Jul 4, 2025

Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment
Published on: May 31, 2024
Ischemic colitis induced by a platelet-raising capsule: A case report
Chen-Lu Wang1, Ze-Kun Si1, Guo-Hong Liu2
1The Affiliated Hospital of Shandong Second Medical University, School of Clinical Medicine, Shandong Second Medical University, Weifang 261000, Shandong Province, China.
Platelet-raising capsules can cause ischemic colitis (IC), a rare condition. Clinicians must carefully consider the risks and benefits of these drugs and monitor patients for adverse effects like abdominal pain and bloody stool.
Area of Science:
- Gastroenterology
- Hematology
- Pharmacology
Background:
- Ischemic colitis (IC) is a condition resulting from reduced blood supply to the colon, leading to intestinal wall ischemia.
- Symptoms include abdominal pain, diarrhea, and bloody stool, with severe cases potentially causing intestinal gangrene or obstruction.
- Drug-induced IC is rare, making this case study significant for understanding potential iatrogenic causes.
Observation:
- A patient presented with abdominal pain and bloody stool, diagnosed with IC.
- Colonic ulcers were suspected to be linked to oral platelet-raising capsules.
- Treatment involved stopping the suspected causative drugs, supportive care, and corticosteroid therapy with platelet infusion.
Findings:
- Platelet-raising capsules were identified as a potential cause of IC in this patient.
- Discontinuation of the drug and appropriate medical intervention led to symptom improvement and stabilization.
- The case highlights a specific drug-induced etiology for ischemic colitis.
Implications:
- Clinicians should be aware of the potential for platelet-raising capsules to induce IC.
- Careful consideration of drug risks versus benefits is crucial when treating thrombocytopenia.
- Close patient monitoring is essential to detect and manage adverse drug reactions promptly.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:

